gotop

GNTbm nano-gold drug delivery platform - Vaucarrin®

Vaucarrin®is a proprietary drug delivery platform developed by GNTbm, which uses GNTbm nano-gold as the core carrier, in combination with effective drugs and targeting agents to form a complex, thereby extending its circulation time in vivo, obtaining effective targeting, and delivering the drug to the diseased tissue or cells.
With the Vaucarrin® drug delivery platform as the core technology, GNTbm has developed two series of anti-cancer products: the first generation of GNTbm nano-gold drugs composed of GNTbm nano-gold (AuNP), PEG, proprietary controlled release linkers, and chemotherapy drugs; and the second generation of GNTbm nano-gold drugs composed of GNTbm nano-gold, PEG, proprietary controlled release linkers, chemotherapy drugs, and monoclonal antibodies for targeted therapy.

Figure 1. Diagram of the first and second generation of GNTbm nano-gold drugs developed with the Vaucarrin® drug delivery platform